ETF overview
The iShares Genomics Immunology and Healthcare ETF (IDNA) is designed to mirror the investment performance of a specific index. This index comprises companies operating in both mature and emerging global markets. These businesses are strategically chosen for their potential to capitalize on sustained innovation and expansion within the crucial fields of genomics, immunology, and bioengineering.
Fund facts
- Expense ratio
- 0.47%
- Fund assets
- 322.45M USD (all share classes)
- Issuer
- iShares
- Inception date
- Jun 11, 2019
- Number of holdings
- 50
Breakdown
Holdings (50)
| Name | Ticker | Weight |
|---|---|---|
| MODERNA | MRNA | 13.90% |
| TWIST BIOSCIENCE | TWST | 5.82% |
| IOVANCE BIOTHERAPEUTICS INC | IOVA | 5.00% |
| GENMAB | GMAB.CO | 4.29% |
| TAKEDA PHARMACEUTICAL | 4502.T | 3.54% |
| REVOLUTION MEDICINES | RVMD | 3.54% |
| REGENERON PHARMACEUTICALS | REGN | 3.49% |
| CARIS LIFE SCIENCES | CAI | 3.40% |
| MERCK & CO INC | MRK | 3.35% |
| EXELIXIS INC | EXEL | 3.32% |
| and 37 more | ||
Historical returns do not guarantee future returns. This is not investment advice.
iShares Genomics Immunology and Healthcare ETF (IDNA)
- Expense ratio
- 0.47%
- Fund assets
- 322.45M USD (all share classes)
- Issuer
- iShares
- Inception date
- Jun 11, 2019
- Number of holdings
- 50
| Name | Ticker | Weight |
|---|---|---|
| MODERNA | MRNA | 13.90% |
| TWIST BIOSCIENCE | TWST | 5.82% |
| IOVANCE BIOTHERAPEUTICS INC | IOVA | 5.00% |
| GENMAB | GMAB.CO | 4.29% |
| TAKEDA PHARMACEUTICAL | 4502.T | 3.54% |
| REVOLUTION MEDICINES | RVMD | 3.54% |
| REGENERON PHARMACEUTICALS | REGN | 3.49% |
| CARIS LIFE SCIENCES | CAI | 3.40% |
| MERCK & CO INC | MRK | 3.35% |
| EXELIXIS INC | EXEL | 3.32% |
| and 37 more | ||
The iShares Genomics Immunology and Healthcare ETF (IDNA) is designed to mirror the investment performance of a specific index. This index comprises companies operating in both mature and emerging global markets. These businesses are strategically chosen for their potential to capitalize on sustained innovation and expansion within the crucial fields of genomics, immunology, and bioengineering.
Unlock all ETF data
Sign up for FreeUnlock all ETF data
Sign up for Free